| Name | Title | Contact Details |
|---|
HeartFlow is a medical technology company transforming the way cardiovascular disease is diagnosed and treated. With our HeartFlow Analysis, a non-invasive personalized cardiac test, physicians are able to make better care decisions for their patients with suspected coronary artery disease--the number one killer of men and women worldwide. HeartFlow is backed by decades of scientific research and development and leverages the latest advancements in technology to help set a new standard of care for diagnosing cardiovascular care worldwide. Cleared for use in the United States, Canada, Europe and Japan and with offices in Redwood City, Austin, London and Japan, HeartFlow`s footprint is growing rapidly. HeartFlow has received more than $240 million dollars in funding in a recent Series E financing round, is pre-IPO and leverages the latest technology including deep learning and computational fluid dynamics. We try to embody the best of both technology and healthcare companies and hire people who are passionate about living our mission to save lives, improve the patient experience and reduce the overall cost of care.
InfraScan, Inc. is a medical device company that focuses on developing, commercializing, and distributing hand-held diagnostic devices for head injury and stroke assessment based on near infrared (NIR) technology. The Infrascanner enables clinicians to detect effectively, conveniently, and accurately intracranial bleeding in patients with head trauma. Intracranial hematomas are an important treatable cause of secondary brain injury in patients with head trauma. Recent statistics from Iraq shows that 30% of all wounded in action have head injuries; of them 40% have brain hematomas. Dr. Britton Chance (University of Pennsylvania) and Dr. Claudia Robertson (Baylor College of Medicine) invented a NIR system for detection of brain Hematomas and tested it successfully in 305 patients in Baylor. An entrepreneurial team formed a company around this technology in Collaboration with Drexel University and won the Wharton Business Plan competition in April 2004 and the second prize at the global business plan competition in Singapore in October 2004. Office of Naval Research funded the company in May 2004. The company also attracted $1.5M in funding from BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania, from Ben Franklin Technology Partners of Southeastern Pennsylvania, and from Philadelphia Industrial Development Corporation. A multicenter clinical study to support an FDA submission started in July 2006, and on February 2008 an application was submitted to the FDA. After 4 years of review, the FDA cleared Infrascanner Model 1000 as a DeNovo medical technology in December 2011. In January 2013 the FDA cleared the 510(k) of Infrascanner Model 2000.
Advanced Reimbursement Management offers a suite of services encompassing Medicaid reimbursement. These service lines include: Medicaid Eligibility Assistance Services – ARM provides both on-site team members to assist with I/P and O/P enrollment of your Self Pay Patients in Medicaid as well as centralized eligibility support team members who do follow up work from our central business office. Accounts Receivables Management – ARM handles a variety of services from initial Medicaid claims billing to follow-up of aged claims at 60,90,120+ days. We use our clinical audit nursing staff to do our own in house reviews when submitting claims for reconsideration. This is an included part of the service at no extra charge. Clinical Auditing Services – ARM provides a variety of clinical auditing services in addition to claims review as part of A/R management. This includes RACs, Defense Audits (all payers), Stop Loss / Carve Out, Charge Hold / Lost Charge. In all situations, ARM provides trending feedback to the hospital in an effort to provide long term solutions. ARM can do both hourly pricing or contingency rate pricing, depending on your preference. Post Payment Review (Zero Balance) – ARM can review all of your Medicaid claims for variance from expected reimbursement amounts, and provide detailed trending, The best part is that we are budget positive because this is truly “found money”
Founded in 1985, Clinical Research Dental is the proud Canadian distributor for a number of internationally renowned dental manufacturers, including Clinician`s Choice, Ultradent, Bioclear, 3M, Cosmedent, Triodent, Komet and Ribbond. The company is also a leading provider of continuing education programs for dentists, and hosts 40 to 50 seminars and hands-on courses across Canada each year.
Scilabs Nutracueticals is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.